Armando Ramirez։ Key Takeaways from NLA’s Updated Clinical Guidance on Familial Hypercholesterolemia
Armando Ramirez, Cardio Genetics and Precision Medicine professional, shared a National Lipid Association post on LinkedIn, adding:
”This is huge…
Here are some of my takeaways:
- Earlier identification through universal pediatric screening, opportunistic adult screening, and systematic cascade testing of families – this is a positive step forward.
- Genetic testing as a powerful complement to clinical diagnosis and family screening (not a barrier to treatment) – as a speciality, we need to be screening more.
- More aggressive LDL-C targets (often <70 mg/dL for primary prevention, <55 mg/dL for secondary prevention) – this will lead to better outcomes.
FH is one of the most preventable causes of premature heart disease. I feel this update moves us closer to proactive, precision-driven, family-centered prevention.”
Quoting National Lipid Association՛s post:
”NOW AVAILABLE: The NLA’s Updated Clinical Guidance on Familial Hypercholesterolemia (FH)
This updated expert clinical consensus on FH reflects more than a decade of advances in screening, diagnosis, and treatment.
- Read the full consensus statement.
- Watch our CME-accredited video podcast with key authors.
- View the press release․
Title: Update on familial hypercholesterolemia: an expert clinical consensus from the National Lipid Association
Authors: Zahid Ahmad, Anandita Agarwala, Marina Cuchel, P. Barton Duell, Robert A. Hegele, Lisa Hudgins, Allison Jamison, Dinesh Kalra, Amit Khera, Joshua W. Knowles, Iftikhar Kullo, Ana Morales, Mark A. Rothstein, Joseph J. Saseen, Daniel Soffer, Bruce A. Warden, William S. Weintraub, Lauren Williams, Anne C. Goldberg
Read the Full Article on Journal of Clinical Lipidology.
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 9, 2026, 14:46Raul Santos: It’s Time Science Wins the War Against Bad Opinions and Lies on Statins
-
Feb 9, 2026, 14:45Heghine Khachatryan: We Already Have The Knowledge Not to Overlook Rare Diseases
-
Feb 9, 2026, 14:42Ed Shovelin: PDE Inhibitors Preferentially Affect ADP and TRAP6 Activation
-
Feb 9, 2026, 14:40Jecko Thachil: Steroids May Be Associated With Arterial and Venous Thrombosis
-
Feb 9, 2026, 14:36Mohammad Reza Fattahi: Breast Arterial Calcifications as a Marker of Stroke Risk in Women
-
Feb 9, 2026, 14:28Shubham Misra: Biomarker Discovery for LVO, AFib Detection, and Post-Stroke Epilepsy at ISC 2026
-
Feb 9, 2026, 14:27Wolfgang Miesbach: Discussing Model-Informed Precision Dosing of Fitusiran at EAHAD 2026
-
Feb 9, 2026, 14:22Valance Washington: An Evidence-Based View on Emerging Therapies for Thrombotic Disorders
-
Feb 9, 2026, 14:19Nathan Connell: Advancing Prophylaxis for von Willebrand Disease with HMB-002